Growth Insights on the US Therapeutic Apheresis Market, Forecast to 2021

Product Diversification, Focus on Therapeutic Plasmapheresis and Pathogen-Reduced Platelets Will Be Key to Success

USD 1,500.00

* Required Fields

USD 1,500.00

PAY BY INVOICE

Be the first to review this product

The study covers current and future market trends, drivers, challenges, and opportunities in US therapeutic apheresis market. It breaks down the market into hematology and oncology, neurology, rheumatology, and other therapeutic areas. Therapeutic apheresis has become an essential element of the blood and blood components industry value chain. Hospitals are the primary users of apheresis equipment and solutions; other users include blood banks and dialysis centers. End users include therapeutic apheresis nurses, referring physicians, hematologists, oncologists, rheumatologists, neurologists, nephrologists, cardiologists, and lipidologists.The study covers standard plasmapheresis or plasma exchange, extracorpore

Table of Contents

Growth Insights on the US Therapeutic Apheresis Market, Forecast to 2021Executive SummaryKey FindingsMarket OverviewMarket DefinitionMarket Scope and SegmentationMarket Scope and Segmentation (continued)Key Questions This Study Will AnswerValue Chain AnalysisMarket TrendsMarket DynamicsMarket Dynamics (continued)Market Impact of Top TrendsRegulatory OverviewReimbursement TrendsDrivers and RestraintsMarket DriversMarket RestraintsForecast and TrendsForecast AssumptionsMarket Forecast ScenariosForecast by Therapeutic CategoryPricing TrendsCompetitive LandscapeCompetitive EnvironmentKey Vendors to WatchKey Service Providers to WatchGrowth Opportunities and Companies to ActionGrowth Opportunity 1—Growing Application and Scope of Therapeutic PlasmapheresisGrowth Opportunity 2—Increasing Focus on Diversifying Product ApplicationsGrowth Opportunity 3—Pathogen-Reduced Platelets and PlasmaStrategic ImperativesECP Treatments—Market Insights ECP Treatments—Market InsightsECP Treatments—Market Insights (continued)AppendixDrivers ExplainedDrivers Explained (continued)Drivers Explained (continued)Restraints ExplainedRestraints Explained (continued)Legal DisclaimerThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition—Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy




Keyword1
therapeutic apheresis
Keyword2
therapeutic plasmapheresis
Keyword3
therapeutic apheresis

Related Research

Release Date : 10-May-18

Region : North America

Release Date : 09-Apr-18

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.